Chapter 13. Risk Assessment
Published Online: 4 JAN 2006
DOI: 10.1002/0471748897.ch13
Copyright © 2006 John Wiley & Sons, Inc.
Book Title

Genetic Testing: Care, Consent, and Liability
Additional Information
How to Cite
Sharpe, N. F. and Carter, R. F. (2006) Risk Assessment, in Genetic Testing: Care, Consent, and Liability, John Wiley & Sons, Inc., Hoboken, NJ, USA. doi: 10.1002/0471748897.ch13
Publication History
- Published Online: 4 JAN 2006
- Published Print: 11 NOV 2005
ISBN Information
Print ISBN: 9780471649878
Online ISBN: 9780471748892
- Summary
- Chapter
Keywords:
- Alport syndrome;
- Bayesian;
- BRCA1;
- BRCA2;
- conditional probability;
- congenital adrenal hypertrophy;
- counseling;
- cystic fibrosis;
- Huntington disease;
- joint probability;
- linkage analysis;
- missense mutations;
- molecular genetic tests;
- posterior probabilities;
- prior probability;
- risk calculation;
- sequence variation
Summary
Risk assessments based upon family history information are commonly refined by genetic test results, e.g. testing informative individuals to determine if a genetic disease is present, testing persons at risk for carrying a mutation, or testing persons at risk for the disease in question. Health care professionals need to be able to understand the limitations of genetic tests, and to know exactly how much a test result modifies the patient's risk. Bayesian analysis, a mathematical approach to quantifying conditional probabilities, is commonly applied in situations where a laboratory result does not provide a conclusive “yes” or “no” answer. Worked examples are provided in a how-to discussion of common testing situations.
